Looking forward to a 10 cent share price, page-19

Super

Imugene management are scientists led by Leslie Chong.

Leslie Chong is one of the most impressive individuals you could meet.

Along with Nick Ede, Axel Hoos, Charles Walker, Anthony Good, Mark Marino,Pravin Kaumaya ,Ursula Wiedermann  and the list goes on.

I have included the ones I have met in person.

My own research has led me to believe that these people are credible, trustworthy, enthusiastic people who dare to research in such an area and have the patients and Investors interest at heart.

I understand the risk with biotech. I could lose my money if science does not stack up. That will all be revealed at the end of the phase 2 trial for Hervaxx. We also still have PD1, Prof Kaumayas Her2 Phase 2 as well and the other 31 patents to research and test.  The first sign of success will be at end of phase 2 for Hervaxx.

That is a wonderful position to be in. This board set the Phase 2 trial up to meet big Pharma requirements to go to phase 3 or be sold off.

After you have met and researched these people ,the integrity and intentions of the key people should never be in question. Thats the wonderful aspect of Imugene. Its run by scientists. Not finance people putting a spin on the smell of a good idea. This is real research led by world leading credible experts. They have more than anyone on the line. Reputation is everything in science world. There is no way the best oncology people would keep coming onto Imugene management structure if they believed it was going to fail. the head of ESMO just joined!

The market got hold of Imugene over the past few months with  a turbulent market we have taken a hit. I am hoping the first qtr of next year sees Imugene share price improving and start to reflect what this company has produced to date. 2018 was a great year for Imugene. More science acquired - Kaumaya and Mayo clinic, more money in the bank, more value, more patents and yet share price tanked. Go figure. The fundamentals will prevail - eventually...

Super, I think its a stretch to believe your doomsday theory with Imugene.

Stay off the red cordial and have a wonderful Christmas and New year and I look forward to hearing what is normally great and informative news from you.

Good luck to all Imugene Shareholders